Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka

Acute Coronary Syndromes

A Companion to Braunwald's Heart Disease

9780721696133
791,28 zł
712,15 zł Zniżka 79,13 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 712,15 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
This book provides a background of the fundamentals of basic science related to acute coronary syndrome in combination with extensive sections on diagnosis and treatment management. The frequency of ACS is on the rise worldwide, and this timely book covers management through pharmacologic therapy and revascularization. The section on pharmacologic agents includes contributions from the world leaders in cardiovascular drug therapy. Coverage of the recent guidelines for acute coronary syndrome management is included with commentary from the Eugene Braunwald. Included in the Companion series to Braunwalds Heart Disease, this book covers the most challenging cardiovascular problem today.
Szczegóły produktu
Saunders
30342
9780721696133
9780721696133

Opis

Rok wydania
2003
Numer wydania
1
Oprawa
twarda
Liczba stron
768
Wymiary (mm)
216 x 276
Waga (g)
2368
  • I. ACS and Clinical Practice
    1. From Pre-Infarction Angina to Acute Coronary Syndromes: The History of Unstable Angina
    2. The Dimension of the Problem, National and International Statistics, The Cost for the Society
    3. An Epidemiological Perspective; Society, Environment, Risk Factors, and Genetic
    4. Natural History and Prognosis in Unstable Angina
    5. Organization and Structure of the Coronary Care Units in the Years 2000

    II. Pathophysiology
    6. Pathology of Acute and Stable Coronary Syndromes
    7. Molecular Mechanisms of the Acute Coronary Syndromes: The Roles of Inflammation and Immunity
    8. Endothelial Function and Acute Coronary Syndromes
    9. Infection
    10. Triggers to Acute Coronary Syndromes
    11. Novel Risk Factors for ACS
    12. What Cardiologists Need to Know about Depression

    III. Diagnosis
    13. Clinical Recognition of Acute Coronary Syndromes
    14. The Role of ECG, ECG Monitoring and Provocative Stress Testing in Acute Coronary Syndromes
    15. Biochemical Markers of Myocardial Necrosis
    16. Markers of a Thrombotic State
    17. Markers of Inflammation
    18. Angiographic Characterization of the Culprit Lesion in ACS
    19. Nuclear Cardiology in Acute Coronary Syndromes
    20. Echocardiography in Acute Coronary Syndromes
    21. Cardiac Magnetic Resonance
    22. Computed Tomography for Acute Coronary Syndromes
    23. Emerging Diagnostic Procedures for Vulnerable Plaque
    24. ACS in the Emergency Department: Diagnosis, Risk Stratification and Management
    25. ACS in the CCU
    26. Risk Stratification in Unstable Angina/Non-ST Elevation Myocardial Infarction

    IV. Special Subgroups
    27. The Elderly, Woman and Patient with Diabetes
    28. Coronary Artery Spasm
    29. Cocaine and Other Environmental Causes of Acute Coronary Syndromes
    30. The Patient with Chest Pain Despite Normal Coronary Angiography
    31. The Patient with Disabling Angina Not Amenable to Revascularization (ECP, TMR, IABC, PMR, spinal chord stimulation)
    V. Pharmacologic Management
    32. Nitrates and Nitric Oxide Donors
    33. Beta-blockers and Calcium Channel Blockers (CCBs): Use in Acute Coronary Syndromes 34. ATP-sensitive Potassium Channels, Adenosine and Preconditioning
    34. ATP-sensitive potassium channels, adenosine Preconditioning
    35. Metabolic Interventions
    36. Antiplatelet Therapy
    · Aspirin
    · The Combination Aspirin-Clopidogrel
    · Other ADP Antagonists
    · The GPIIb/IIIa Antagonists
    · New Antiplatelet Agents
    37. Anticoagulants in Acute Coronary Syndromes
    38. Anti-thrombotic Management
    39. Treatment of Cardiovascular Inflammation
    40. Acute Plaque Passivation and Endothelial Therapy
    41. Perspective for Gene Therapy
    42. Myocardial cell protection

    VI. Revascularization
    43. Revascularization in Acute Coronary Syndromes: Which Patients and When?
    44. Advantages and Hazard of Early Revascularization
    45. New Revascularization Procedures, Surgical and Percutaneous
    46. Cardiovascular Regeneration and Stem Cell Differentiation in Myocardial Ischemia
    47. Pharmacological Revascularization

    VII. From the Acute to the Chronic Phase
    48. Control of Risk Factors
    49. Dietary Intervention in the Coronary Care Units and in Secondary Prevention

    VIII. Outlook to the Future
    50. ACS: Outlook to the Future


    IX. Guidelines for Management
    51. Guidelines for Management: AHA/ACC and ESC Task Forces
Komentarze (0)

  • Często kupowane razem

    Brak dostępnych produktów